Semler Scientific, Inc. (SMLR) faced a significant 13% plunge in its stock price during Friday's pre-market trading session, underperforming the broader market. The healthcare technology firm's shares took a hit following the announcement of an upsized $85 million convertible senior notes offering, raising concerns about potential equity dilution.
The company revealed plans to issue the convertible notes due 2030 in a private offering to institutional buyers. While the initial offering size was set at $75 million, strong demand prompted Semler Scientific to upsize the offering to $85 million, with an option to purchase an additional $15 million worth of notes.
Investors reacted negatively to the news, as convertible debt offerings often lead to the issuance of new shares when the notes are converted, diluting existing shareholders' stakes. Additionally, Semler Scientific stated its intention to use a portion of the proceeds to fund capped call transactions and acquire bitcoin as part of its bitcoin treasury strategy, further fueling concerns about the company's capital allocation decisions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.